Cargando…

Aripiprazole in the treatment of Huntington’s disease: a case series

OBJECTIVES: The aim of the study was to describe the effects of aripiprazole, a new atypical antipsychotic drug that acts as a partial dopamine agonist on motor, behavioral and cognitive functions in patients with genetically confirmed Huntington’s disease (HD). METHODS AND RESULTS: Three HD patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ciammola, Andrea, Sassone, Jenny, Colciago, Clarissa, Mencacci, Niccolò E, Poletti, Barbara, Ciarmiello, Andrea, Squitieri, Ferdinando, Silani, Vincenzo
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2009
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695210/ https://www.ncbi.nlm.nih.gov/pubmed/19557093

Ejemplares similares

Low Anaerobic Threshold and Increased Skeletal Muscle Lactate Production in Subjects with Huntington's Disease
por: Ciammola, Andrea, et al.
Publicado: (2011)

Atypical Parkinsonism Revealing a Late Onset, Rigid and Akinetic Form of Huntington's Disease
por: Ciammola, A., et al.
Publicado: (2011)

Counterfactual Thinking Deficit in Huntington’s Disease
por: Solca, Federica, et al.
Publicado: (2015)

Defining the role of the Bcl-2 family proteins in Huntington's disease
por: Sassone, J, et al.
Publicado: (2013)

Diagnostic properties of the Frontal Assessment Battery (FAB) in Huntington’s disease
por: Solca, Federica, et al.
Publicado: (2022)

Fiberoptic endoscopic evaluation of swallowing in early-to-advanced stage Huntington’s disease
por: Schindler, Antonio, et al.
Publicado: (2020)

Early defect of transforming growth factor β(1) formation in Huntington’s disease
por: Battaglia, Giuseppe, et al.
Publicado: (2011)

Semiology and determinants of apathy across neurodegenerative motor disorders: A comparison between amyotrophic lateral sclerosis, Parkinson’s and Huntington’s disease
por: Poletti, Barbara, et al.
Publicado: (2022)

Neuropsychiatric Burden in Huntington’s Disease
por: Paoli, Ricardo Augusto, et al.
Publicado: (2017)

A Novel Mutation of GFAP Causing Adult-Onset Alexander Disease
por: Ciammola, Andrea, et al.
Publicado: (2019)

Mutant Huntingtin induces activation of the Bcl-2/adenovirus E1B 19-kDa interacting protein (BNip3)
por: Sassone, J, et al.
Publicado: (2010)

Early Dyskinesias in Parkinson’s Disease Patients With Parkin Mutation: A Primary Corticostriatal Synaptopathy?
por: Sassone, Jenny, et al.
Publicado: (2019)

Profile of pridopidine and its potential in the treatment of Huntington disease: the evidence to date
por: Squitieri, Ferdinando, et al.
Publicado: (2015)

Impaired Expression of Insulin-Like Growth Factor-1 System in Skeletal Muscle of Amyotrophic Lateral Sclerosis Patients
por: Lunetta, Christian, et al.
Publicado: (2012)

Brain-Derived Neurotrophic Factor in Patients with Huntington's Disease
por: Zuccato, Chiara, et al.
Publicado: (2011)

Genetic Counseling in Huntington's Disease: Potential New Challenges on Horizon?
por: Migliore, Simone, et al.
Publicado: (2019)

Parkin regulates kainate receptors by interacting with the GluK2 subunit
por: Maraschi, AnnaMaria, et al.
Publicado: (2014)

A Novel Approach for Investigating Parkinson’s Disease Personality and Its Association With Clinical and Psychological Aspects
por: Carelli, Laura, et al.
Publicado: (2019)

Counterfactual thinking in psychiatric and neurological diseases: A scoping review
por: Tagini, Sofia, et al.
Publicado: (2021)

Clinimetrics of the Italian version of the Montreal Cognitive Assessment (MoCA) in adult-onset idiopathic focal dystonia
por: D’Iorio, Alfonsina, et al.
Publicado: (2023)

Brain-Computer Interface for Clinical Purposes: Cognitive Assessment and Rehabilitation
por: Carelli, Laura, et al.
Publicado: (2017)

Aripiprazole in the Treatment of Refractory Mood Disorders: A Case Series
por: Muneer, Ather
Publicado: (2014)

Cognitive-constructivist Approach in Medical Settings: The Use of Personal Meaning Questionnaire for Neurological Patients’ Personality Investigation
por: Poletti, Barbara, et al.
Publicado: (2017)

Safer Attitude to Risky Decision-Making in Premanifest Huntington’s Disease Subjects
por: D’Aurizio, Giulia, et al.
Publicado: (2019)

Parkinsonian Syndromes in Motor Neuron Disease: A Clinical Study
por: Pasquini, Jacopo, et al.
Publicado: (2022)

Validity and diagnostics of the Italian version of the Montreal Cognitive Assessment (MoCA) in non-demented Parkinson’s disease patients
por: D’Iorio, Alfonsina, et al.
Publicado: (2023)

The Complex Interplay Between Depression/Anxiety and Executive Functioning: Insights From the ECAS in a Large ALS Population
por: Carelli, Laura, et al.
Publicado: (2018)

Sleep Quality and Related Clinical Manifestations in Huntington Disease
por: Maffi, Sabrina, et al.
Publicado: (2022)

Deep White Matter in Huntington's Disease
por: Phillips, Owen, et al.
Publicado: (2014)

DNA instability in replicating Huntington's disease lymphoblasts
por: Cannella, Milena, et al.
Publicado: (2009)

Current Diagnostic Methods and Non-Coding RNAs as Possible Biomarkers in Huntington’s Disease
por: Pellegrini, Miguel, et al.
Publicado: (2022)

The Arrows and Colors Cognitive Test (ACCT): A new verbal-motor free cognitive measure for executive functions in ALS
por: Poletti, Barbara, et al.
Publicado: (2018)

Regenerative Approaches in Huntington’s Disease: From Mechanistic Insights to Therapeutic Protocols
por: Sassone, Jenny, et al.
Publicado: (2018)

Tractography of the Corpus Callosum in Huntington’s Disease
por: Phillips, Owen, et al.
Publicado: (2013)

Treatment persistence with aripiprazole once monthly: a 4-year follow-up
por: Fagiolini, Andrea, et al.
Publicado: (2022)

Current Pharmacological Management in Juvenile Huntington’s Disease
por: Robertson, Lisa, et al.
Publicado: (2012)

International Guidelines for the Treatment of Huntington's Disease
por: Bachoud-Lévi, Anne-Catherine, et al.
Publicado: (2019)

Is aripiprazole a key to unlock anorexia nervosa?: A case series
por: Tahıllıoğlu, Akın, et al.
Publicado: (2020)

Nitric Oxide Dysregulation in Platelets from Patients with Advanced Huntington Disease
por: Carrizzo, Albino, et al.
Publicado: (2014)

Emotion recognition and inhibitory control in manifest and pre-manifest Huntington's disease: evidence from a new Stroop task
por: Hünefeldt, Thomas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_caocufqh21uhcsg7cvu7j1f82s